Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cg Oncology Inc | Hong Fang Song | Director | 29 Jan 2024 | 37,474,236 | 0 | - | - | Series E Preferred Stock | ||
| Cg Oncology Inc | Hong Fang Song | Director | 29 Jan 2024 | 6,262,967 | 0 | - | - | Series C Preferred Stock | ||
| Intuitive Machines Inc (Class A) | Kamal Seyed Ghaffarian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 4,150,780 | 4,150,780 | - | - | Series A Warrant | |
| Intuitive Machines Inc (Class A) | Ghaffarian Kamal Seyed | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 4,150,780 | 4,150,780 | - | - | Series B Warrant | |
| Cg Oncology Inc | Hong Fang Song | Director | 29 Jan 2024 | 3,930,176 | 3,930,176 | - | - | Common Stock | ||
| Intuitive Machines Inc (Class A) | Seyed Kamal Ghaffarian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 3,487,278 | 3,551,606 | - | - | Class A Common Stock | |
| Cg Oncology Inc | Hong Fang Song | Director | 29 Jan 2024 | 3,378,758 | 0 | - | - | Series D Preferred Stock | ||
| Cg Oncology Inc | Hong Fang Song | Director | 29 Jan 2024 | 3,344,608 | 0 | - | - | Series B Preferred Stock | ||
| Minim Inc | David E. Lazar | Director, Ten Percent Owner | 29 Jan 2024 | 2,800,000 | 2,800,000 | - | - | Warrants | ||
| Minim Inc | Lazar E. David | Director, Ten Percent Owner | 29 Jan 2024 | 2,000,000 | 2,000,000 | - | - | Series A Convertible Preferred Stock | ||
| Akoustis Technologies Inc | Jeffrey B. Shealy | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 29 Jan 2024 | 1,310,000 | 2,222,775 (6%) | 3% | 0.5 | 655,000 | Common Stock |
| Cg Oncology Inc | Hong Fang Song | Director | 29 Jan 2024 | 1,011,192 | 1,011,192 | - | - | Common Stock | ||
| DraftKings Inc (Class A) | Paul Liberman | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 29 Jan 2024 | 510,000 | 2,291,406 | - | 40 | 20,400,000 | Class A Common Stock |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | 29 Jan 2024 | 470,000 | 470,000 | - | - | Employee Stock Option (right to buy) | ||
| Compass Inc (Class A) | Wahlers Scott | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 365,070 | 365,070 | - | - | Restricted Stock Unit (RSU) | |
| Exlservice Hldgs Inc | Rohit Kapoor | Director, CEO & Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 354,000 | 1,501,840 (4%) | 1% | 0 | Common Stock, par value $0.001 per share | |
| Cg Oncology Inc | Hong Fang Song | Director | 29 Jan 2024 | 350,771 | 350,771 | - | - | Common Stock | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Gass Michelle D. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 320,610 | 320,610 | - | - | Stock Appreciation Rights | |
| Goodyear Tire & Rubber Co. | Mark Stewart | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 291,156 | 291,156 (0%) | 0% | 0 | Common Stock | |
| Griffon Corp | J. Ronald Kramer | Director, Chairman of the Board and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.99 per share. | 29 Jan 2024 | 267,924 | 2,600,746 (5%) | 0% | 61.0 | 16,340,685 | Common Stock |
| Cg Oncology Inc | Hong Fang Song | Director | 29 Jan 2024 | 263,157 | 613,928 | - | 19 | 4,999,983 | Common Stock | |
| WisdomTree Inc | L. Steinberg Jonathan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 260,618 | 9,002,103 (5%) | 0% | 0 | Common Stock | |
| WisdomTree Inc | L. Jonathan Steinberg | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 260,618 | 0 | - | - | Performance Based Restricted Stock Units | |
| Upland Software Inc | John T. Mcdonald | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 250,000 | 1,881,748 (7%) | 0% | 0 | Common Stock | |
| Upland Software Inc | Mcdonald T. John | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 250,000 | 250,000 | - | - | Performance Share Unit | |
| Upland Software Inc | John T. Mcdonald | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 250,000 | 250,000 | - | - | Performance Share Unit | |
| Upland Software Inc | John T. Mcdonald | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 250,000 | 1,881,748 (7%) | 0% | 0 | Common Stock | |
| Las Vegas Sands | G. Goldstein Robert | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 222,470 | 222,470 | - | - | Restricted Stock Units | |
| Jade Biosciences Inc | P. Timothy Noyes | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| A10 Networks Inc | Trivedi Dhrupad | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 198,821 | 198,821 | - | - | Performance-based Restricted Stock Units | |
| Leap Therapeutics Inc | Onsi Douglas E. | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 170,000 | 170,000 | - | - | Employee Stock Option (Right to Buy) | |
| GSI Tech Inc | Shu Lee-Lean | Director, Pres., CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Upland Software Inc | Doman Dan | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 150,000 | 341,271 (1%) | 0% | 0 | Common Stock | |
| Vor Biopharma Inc | Robert Ang | Director, PRESIDENT AND CEO | 29 Jan 2024 | 150,000 | 830,925 | - | 0 | Common Stock | ||
| Methode Electronics Inc | Avi Avula | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 144,877 | 144,877 (0%) | 0% | 0 | Common Stock | |
| WisdomTree Inc | Jarrett R. | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 143,386 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | Jarrett R. | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 143,386 | 1,027,744 (0%) | 0% | 0 | Common Stock | |
| Griffon Corp | Ronald Kramer J. | Director, Chairman of the Board and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 135,000 | 2,868,670 (6%) | 0% | 0 | Common Stock | |
| Upland Software Inc | Oliver Robert MacFarlane Yates | Chief Sales Officer | 29 Jan 2024 | 135,000 | 258,239 (1%) | 0% | 0 | Common Stock | ||
| WisdomTree Inc | L. Jonathan Steinberg | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Jan 2024 | 133,046 | 8,869,057 (5%) | 0% | 0 | Common Stock | |
| A10 Networks Inc | Dhrupad Trivedi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 132,549 | 594,056 (0%) | 0% | 0 | Common Stock | |
| Levi Strauss & Co. - Ordinary Shares Cls A | D. Michelle Gass | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 131,909 | 471,857 (0%) | 0% | 0 | Class A Common Stock | |
| Vor Biopharma Inc | C. Eyal Attar | CHIEF MEDICAL OFFICER | 29 Jan 2024 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | ||
| Goodyear Tire & Rubber Co. | Stewart Mark | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.70 per share. | 29 Jan 2024 | 122,424 | 168,732 (0%) | 0% | 14.7 | 1,799,633 | Common Stock |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 119,386 | 119,386 | - | - | Restricted Stock Units | |
| Myriad Genetics Inc | J. Scott Leffler | Chief Financial Officer | 29 Jan 2024 | 117,770 | 117,770 (0%) | 0% | 0 | Common Stock | ||
| AMEX | J. Stephen Squeri | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 115,740 | 249,898 (0%) | 0% | 201.4 | 23,313,508 | Common Stock |
| Comcast (Class A) | J. Cavanagh Michael | President | Sale of securities on an exchange or to another person at price $ 46.10 per share. | 29 Jan 2024 | 114,749 | 0 (0%) | 0% | 46.1 | 5,290,193 | Class A Common Stock |
| Las Vegas Sands | Patrick Dumont | Director, President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 114,087 | 114,087 | - | - | Restricted Stock Units | |
| SL Green Realty Corp | Holliday Marc | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 110,679 | 1,239,216 | - | - | LTIP Units | |
| Fiserv | Bisignano J. Frank | Director, Chairman, President and CEO | 29 Jan 2024 | 108,423 | 3,001,087 (0%) | 0% | 0 | Common Stock | ||
| Vor Biopharma Inc | Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | 29 Jan 2024 | 107,500 | 107,500 | - | - | Employee Stock Option (right to buy) | ||
| Appfolio Inc (Class A) | Schauser Klaus | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2024 | 100,000 | 300,000 (1%) | 0% | 0 | Class A Common Stock | |
| Appfolio Inc (Class A) | Klaus Schauser | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2024 | 100,000 | 200,000 (1%) | 0% | 0 | Class A Common Stock | |
| Odyssey Marine Exploration Inc | Gordon D. Mark | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Odyssey Marine Exploration Inc | D. John Longley | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 100,000 | 100,000 | - | - | Stock Option(Right to Buy) | |
| Upland Software Inc | Michael D. Hill | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 100,000 | 350,804 (1%) | 0% | 0 | Common Stock | |
| Vor Biopharma Inc | Nathan Jorgensen | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Sobr Safe Inc | Gary Graham | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 29 Jan 2024 | 98,744 | 0 | - | 0.7 | 68,133 | Common Stock |
| SL Green Realty Corp | Holliday Marc | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 97,096 | 1,128,537 | - | - | LTIP Units | |
| Levi Strauss & Co. - Ordinary Shares Cls A | Harmit Singh J. | EVP & Chief Fin. & Growth Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 95,419 | 95,419 | - | - | Stock Appreciation Rights | |
| AMEX | Squeri J. Stephen | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 90,766 | 90,766 | - | - | Employee Stock Option (Right to Buy) | |
| Salesforce | Benioff Marc | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 90,030 | 90,030 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Exelon | Butler Calvin G. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 88,836 | 88,836 | - | - | 2024 Restricted Stock Units | |
| SL Green Realty Corp | Andrew Mathias W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 88,543 | 980,457 | - | - | LTIP Units | |
| Apollo Commercial Real Estate Finance Inc | A. Stuart Rothstein | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.71 per share. | 29 Jan 2024 | 86,383 | 455,292 (0%) | 0% | 11.7 | 1,011,545 | Common Stock |
| Leap Therapeutics Inc | Granfield Christine | VP, Head of Reg Affairs/Qual | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Sirard Cynthia | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Jason Baum | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | J. Augustine Lawlor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Mark O’Mahony | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Mirabelli Christopher K. | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Security National Fin Corp (Class A) | Andrew Quist S. | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 84,000 | 414,467 | - | - | Employee Stock Option (right to buy) | |
| Alpha Metallurgical Resources Inc | Whitehead E. Jason | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 80,812 | 113,828 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 80,527 | 80,527 | - | - | Restricted Stock Units | |
| Viemed Healthcare Inc | Michael Moore | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 80,527 | 80,527 | - | - | Restricted Stock Units | |
| Akoustis Technologies Inc | M. Aichele David | EVP of Business Development | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 29 Jan 2024 | 80,000 | 334,622 (0%) | 0% | 0.5 | 40,000 | Common Stock |
| Security National Fin Corp (Class A) | Quist S. Andrew | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 80,000 | 494,467 | - | - | Employee Stock Option (right to buy) | |
| Greenidge Generation Holdings Inc (Class A) | Irwin Dale | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 77,245 | 0 | - | - | Class B Common Stock | |
| Greenidge Generation Holdings Inc (Class A) | Dale Irwin | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 77,245 | 77,245 | - | - | Class A Common Stock | |
| WisdomTree Inc | Jarrett R. | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Jan 2024 | 76,016 | 951,728 (0%) | 0% | 0 | Common Stock | |
| ON24 Inc | Sharan Sharat | Director, President and Chief Executive, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 75,976 | 2,577,335 | - | 0 | Common Stock | |
| Alpha Metallurgical Resources Inc | Andrew Eidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 74,595 | 115,956 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Exlservice Hldgs Inc | Vikas Bhalla | EVP & Head of Outsourcing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 73,400 | 161,509 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| SL Green Realty Corp | Marc Holliday | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 71,031 | 1,334,079 | - | - | LTIP Units | |
| Exlservice Hldgs Inc | Nicolelli Maurizio | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 69,200 | 160,035 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Celsius Holdings Inc | Milmoe William H. | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 53.55 per share. | 29 Jan 2024 | 67,877 | 30,711,936 (44%) | 0% | 53.6 | 3,634,915 | Common Stock |
| Celsius Holdings Inc | William Milmoe H. | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 53.55 per share. | 29 Jan 2024 | 67,877 | 30,651,471 (44%) | 0% | 53.6 | 3,634,915 | Common Stock |
| Celsius Holdings Inc | Milmoe William H. | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 52.56 per share. | 29 Jan 2024 | 67,641 | 31,644,295 (45%) | 0% | 52.6 | 3,555,252 | Common Stock |
| Celsius Holdings Inc | William Milmoe H. | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 52.56 per share. | 29 Jan 2024 | 67,641 | 30,583,830 (44%) | 0% | 52.6 | 3,555,252 | Common Stock |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 51.48 per share. | 29 Jan 2024 | 67,376 | 30,576,919 (44%) | 0% | 51.5 | 3,468,658 | Common Stock |
| Celsius Holdings Inc | H. Milmoe William | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 51.48 per share. | 29 Jan 2024 | 67,376 | 30,516,454 (44%) | 0% | 51.5 | 3,468,658 | Common Stock |
| Security National Fin Corp (Class A) | S. Quist Andrew | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 66,150 | 330,467 | - | - | Employee Stock Option (right to buy) | |
| Alcoa Corp | F. William Oplinger | Director, President, CEO & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 65,899 | 234,635 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| TE Connectivity | Steven T. Merkt | President, Transportation Sol. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.36 per share. | 29 Jan 2024 | 65,550 | 130,236 (0%) | 0% | 93.4 | 6,119,748 | Common Shares |
| TE Connectivity | T. Steven Merkt | President, Transportation Sol. | Sale of securities on an exchange or to another person at price $ 144.00 per share. | 29 Jan 2024 | 65,550 | 30,459 (0%) | 0% | 144 | 9,439,200 | Common Shares |
| TE Connectivity | Merkt T. Steven | President, Transportation Sol. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 65,550 | 0 | - | - | Stock Option (Right to Buy) | |
| Griffon Corp | Mehmel Robert F. | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.99 per share. | 29 Jan 2024 | 64,928 | 812,914 (1%) | 0% | 61.0 | 3,959,959 | Common Stock |
| Baker Hughes | Lorenzo Simonelli | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 64,725 | 0 | - | - | Restricted Stock Unit 01_21 | |
| Baker Hughes | Lorenzo Simonelli | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 64,725 | 599,743 (0%) | 0% | - | Class A Common Stock | |
| Exelon | Calvin Butler G. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 64,301 | 166,379 (0%) | 0% | - | Common Stock | |
| Exelon | Calvin Butler G. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 64,301 | 0 | - | - | 2021-2023 Performance Shares | |
| Exelon | Butler G. Calvin | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 64,301 | 64,301 | - | - | 2021-2023 Performance Shares | |
| Crane Holdings Co. | Mitchell Max H. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 63,389 | 387,724 (0%) | 0% | 0 | Common Stock | |
| Vor Biopharma Inc | Eyal Attar C. | CHIEF MEDICAL OFFICER | 29 Jan 2024 | 62,500 | 114,033 | - | 0 | Common Stock | ||
| Celsius Holdings Inc | William Milmoe H. | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 29 Jan 2024 | 60,465 | 30,719,348 (44%) | 0% | 33.3 | 2,015,298 | Common Stock |
| Celsius Holdings Inc | H. William Milmoe | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 29 Jan 2024 | 60,462 | 30,779,813 (44%) | 0% | 33.3 | 2,015,198 | Common Stock |
| Celsius Holdings Inc | Milmoe William H. | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 29 Jan 2024 | 60,462 | 30,840,275 (44%) | 0% | 33.3 | 2,015,198 | Common Stock |
| Celsius Holdings Inc | H. Milmoe William | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 29 Jan 2024 | 60,462 | 30,900,737 (44%) | 0% | 33.3 | 2,015,198 | Common Stock |
| Celsius Holdings Inc | H. William Milmoe | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 29 Jan 2024 | 60,462 | 30,840,275 (44%) | 0% | 33.3 | 2,015,198 | Common Stock |
| Celsius Holdings Inc | H. William Milmoe | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 29 Jan 2024 | 60,462 | 30,779,813 (44%) | 0% | 33.3 | 2,015,198 | Common Stock |
| Akoustis Technologies Inc | E. Kenneth Boller | CFO | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 29 Jan 2024 | 60,000 | 214,957 (0%) | 0% | 0.5 | 30,000 | Common Stock |
| Exlservice Hldgs Inc | Jetley Vivek | EVP and Head of Analytics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 59,550 | 356,446 (1%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| AMEX | Squeri Stephen J. | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.43 per share. | 29 Jan 2024 | 58,384 | 191,514 (0%) | 0% | 201.4 | 11,760,289 | Common Stock |
| SL Green Realty Corp | Mathias W. Andrew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 56,825 | 1,056,348 | - | - | LTIP Units | |
| Las Vegas Sands | G. Robert Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 55,589 | 55,589 (0%) | 0% | 0 | Common Stock | |
| Las Vegas Sands | G. Goldstein Robert | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 55,589 | 112,862 | - | - | Restricted Stock Units | |
| Alpha Metallurgical Resources Inc | Roger Nicholson L. | CAO, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 55,256 | 76,798 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Vor Biopharma Inc | Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | 29 Jan 2024 | 53,750 | 187,702 | - | 0 | Common Stock | ||
| Ameriprise Financial | Cracchiolo M. James | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 53,506 | 218,598 (0%) | 0% | 0 | Common Stock | |
| Fiserv | Bisignano Frank J. | Director, Chairman, President and CEO | 29 Jan 2024 | 52,975 | 2,948,112 (0%) | 0% | 142.9 | 7,570,657 | Common Stock | |
| Coursera Inc | Maggioncalda Jeffrey N. | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 29 Jan 2024 | 50,000 | 2,551,930 | - | 20.1 | 1,002,895 | Common Stock |
| Coursera Inc | Maggioncalda N. Jeffrey | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.56 per share. | 29 Jan 2024 | 50,000 | 2,601,930 | - | 2.6 | 128,000 | Common Stock |
| Coursera Inc | Jeffrey Maggioncalda N. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 50,000 | 276,656 | - | - | Stock Option (right to buy) | |
| Akoustis Technologies Inc | Geiss E. Arthur | Director | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 29 Jan 2024 | 50,000 | 415,924 (1%) | 0% | 0.5 | 25,000 | Common Stock |
| Blue Bird Corp | Philip Horlock | Chief Executive Officer | 29 Jan 2024 | 50,000 | 449,812 (1%) | 0% | 29 | 1,450,000 | Common Stock, par value $0.0001 per share | |
| BuzzFeed Inc (Class A) | Johnson S. John | Member of 10% Group | Sale of securities on an exchange or to another person at price $ 0.19 per share. | 29 Jan 2024 | 50,000 | 4,780,779 | - | 0.2 | 9,440 | Class A Common Stock |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.12 per share. | 29 Jan 2024 | 50,000 | 237,377 (0%) | 0% | 19.1 | 956,000 | Common Shares |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 50,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Vor Biopharma Inc | Jorgensen Nathan | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 50,000 | 198,449 | - | 0 | Common Stock | |
| Upland Software Inc | Matthew H. Smith | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 50,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Security National Fin Corp (Class A) | Andrew Quist S. | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 49,836 | 216,854 | - | - | Employee Stock Option (right to buy) | |
| Levi Strauss & Co. - Ordinary Shares Cls A | O’Neill Elizabeth | EVP & Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 49,618 | 49,618 | - | - | Stock Appreciation Rights | |
| CRISPR Therapeutics AG | Kulkarni Samarth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.50 per share. | 29 Jan 2024 | 49,300 | 188,077 (0%) | 0% | 60.5 | 2,982,803 | Common Shares |
| Beacon Fin Corp | A. Zaitzeff Michael | Director | Sale of securities on an exchange or to another person at price $ 25.19 per share. | 29 Jan 2024 | 49,154 | 349,785 (0%) | 0% | 25.2 | 1,238,332 | Common Stock |
| Security National Fin Corp (Class A) | Andrew S. Quist | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 47,463 | 264,317 | - | - | Employee Stock Option (right to buy) | |
| Exlservice Hldgs Inc | Anita Mahon | EVP & Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 47,200 | 103,659 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| AMEX | Douglas Buckminster E. | Vice Chairman | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 47,093 | 135,468 (0%) | 0% | 201.4 | 9,485,943 | Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Tracy Layney | EVP and Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 45,801 | 45,801 | - | - | Stock Appreciation Rights | |
| Griffon Corp | Mehmel Robert F. | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 45,000 | 877,842 (1%) | 0% | 0 | Common Stock | |
| P&G | Ma. Francisco Fatima | CEO - Baby, Fem & Family Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 45,000 | 45,323 | - | - | Stock Option (Right to Buy) | |
| P&G | Fatima Francisco Ma. | CEO - Baby, Fem & Family Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.52 per share. | 29 Jan 2024 | 45,000 | 45,973 (0%) | 0% | 78.5 | 3,533,400 | Common Stock |
| P&G | Francisco Ma. Fatima | CEO - Baby, Fem & Family Care | Sale of securities on an exchange or to another person at price $ 156.00 per share. | 29 Jan 2024 | 45,000 | 973 (0%) | 0% | 156 | 7,020,000 | Common Stock |
| Palo Alto | Klarich Lee | EVP, Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 45,000 | 1,472,079 | - | - | Stock Option (right to buy) | |
| Palo Alto | Klarich Lee | EVP, Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.50 per share. | 29 Jan 2024 | 45,000 | 243,105 (0%) | 0% | 64.5 | 2,902,649 | Common Stock |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 29 Jan 2024 | 44,770 | 44,770 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 29 Jan 2024 | 44,770 | 1,470,638 | - | - | Class B Common Stock | ||
| Privia Health Group Inc | Fargis Edward C. | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 44,404 | 44,404 | - | 0 | Common Stock, $0.01 par value per share | |
| Alpha Metallurgical Resources Inc | Whitehead E. Jason | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.05 per share. | 29 Jan 2024 | 43,990 | 69,838 (0%) | 0% | 386.1 | 16,982,340 | Common Stock, $0.01 par value per share |
| AMEX | Campbell Jeffery C. | Vice Chairman | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 42,304 | 167,950 (0%) | 0% | 201.4 | 8,521,295 | Common Stock |
| Exelon | Butler Calvin G. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.29 per share. | 29 Jan 2024 | 42,240 | 124,139 (0%) | 0% | 35.3 | 1,490,650 | Common Stock |
| Beacon Fin Corp | A. Zaitzeff Michael | Director | Sale of securities on an exchange or to another person at price $ 25.08 per share. | 29 Jan 2024 | 41,274 | 308,511 (0%) | 0% | 25.1 | 1,035,069 | Common Stock |
| Relmada Therapeutics Inc | Traversa Sergio | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.90 per share. | 29 Jan 2024 | 40,999 | 216,564 (1%) | 0% | 3.9 | 159,949 | Common Stock |
| SL Green Realty Corp | DiLiberto Matthew | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 40,534 | 227,484 | - | - | LTIP Units | |
| Cullinan Oncology Inc | Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 29 Jan 2024 | 40,000 | 205,990 | - | 4.3 | 172,000 | Common Stock |
| Cullinan Oncology Inc | Savill Corinne | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.09 per share. | 29 Jan 2024 | 40,000 | 165,990 | - | 14.1 | 563,600 | Common Stock |
| Viemed Healthcare Inc | Casey Hoyt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 39,796 | 39,796 | - | - | Phantom Share Units | |
| Levi Strauss & Co. - Ordinary Shares Cls A | Singh J. Harmit | EVP & Chief Fin. & Growth Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 39,258 | 871,892 (1%) | 0% | 0 | Class A Common Stock | |
| AMEX | Anre D. Williams | Group Pres., Enterprise Serv. | 29 Jan 2024 | 38,712 | 170,499 (0%) | 0% | 201.4 | 7,797,758 | Common Stock | |
| Alpha Metallurgical Resources Inc | Daniel E. Horn | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 38,679 | 55,867 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| AMEX | Buckminster Douglas E. | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 36,932 | 36,932 | - | - | Employee Stock Option (Right to Buy) | |
| Exelon | Glockner David | EVP Compliance, Audit & Risk | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 36,523 | 36,523 | - | - | 2021-2023 Performance Shares | |
| Exelon | David Glockner | EVP Compliance, Audit & Risk | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 36,523 | 70,997 (0%) | 0% | - | Common Stock | |
| Exelon | David Glockner | EVP Compliance, Audit & Risk | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 36,523 | 0 | - | - | 2021-2023 Performance Shares | |
| Alpha Metallurgical Resources Inc | Eidson Andrew | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.05 per share. | 29 Jan 2024 | 35,931 | 80,025 (0%) | 0% | 386.1 | 13,871,163 | Common Stock, $0.01 par value per share |
| Crane Holdings Co. | Max H. Mitchell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 35,692 | 0 | - | - | 2021 Performance-Based Restricted Share Unit | |
| AMEX | Laureen E. Seeger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 35,120 | 99,022 (0%) | 0% | 201.4 | 7,074,222 | Common Stock |
| TE Connectivity | Steven T. Merkt | President, Transportation Sol. | Sale of securities on an exchange or to another person at price $ 144.00 per share. | 29 Jan 2024 | 34,227 | 96,009 (0%) | 0% | 144 | 4,928,688 | Common Shares |
| Las Vegas Sands | A. Randy Hyzak | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 34,226 | 34,226 | - | - | Restricted Stock Units | |
| Intuitive Surgical | Gary S. Guthart | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.02 per share. | 29 Jan 2024 | 33,750 | 33,750 (0%) | 0% | 51.0 | 1,721,777 | Common Stock |
| Intuitive Surgical | S. Gary Guthart | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 33,750 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Alcoa Corp | Jones Tammi A | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 33,286 | 84,528 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| AMEX | C. Jeffery Campbell | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 33,176 | 33,176 | - | - | Employee Stock Option (Right to Buy) | |
| WisdomTree Inc | Alexis Marinof | Head of Europe | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 33,072 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | Marinof Alexis | Head of Europe | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 33,072 | 288,469 (0%) | 0% | 0 | Common Stock | |
| Security National Fin Corp (Class A) | Andrew Quist S. | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 32,705 | 167,018 | - | - | Employee Stock Option (right to buy) | |
| Caesars Entertainment | Reeg Thomas R. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 32,546 | 460,466 (0%) | 0% | 0 | Common Stock | |
| Caesars Entertainment | R. Thomas Reeg | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 32,546 | 65,092 | - | - | Restricted Stock Unit | |
| Viemed Healthcare Inc | Jeremy Trahan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 32,321 | 32,321 | - | - | Restricted Stock Units | |
| Exelon | Littleton Gayle | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 32,151 | 32,151 | - | - | 2021-2023 Performance Shares | |
| Exelon | Gayle Littleton | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 32,151 | 73,226 (0%) | 0% | - | Common Stock | |
| Exelon | Gayle Littleton | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 32,151 | 0 | - | - | 2021-2023 Performance Shares | |
| AMEX | Marrs Anna | Group Pres., GCS and CFR | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 31,927 | 48,077 (0%) | 0% | 201.4 | 6,431,056 | Common Stock |
| WisdomTree Inc | Ziemba Peter M. | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 31,866 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | Peter M. Ziemba | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 31,866 | 1,059,874 (0%) | 0% | 0 | Common Stock | |
| Security National Fin Corp (Class A) | Andrew S. Quist | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 31,803 | 47,704 | - | - | Employee Stock Option (right to buy) | |
| Relmada Therapeutics Inc | Traversa Sergio | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.71 per share. | 29 Jan 2024 | 31,541 | 175,565 (1%) | 0% | 3.7 | 117,036 | Common Stock |
| Natural Gas Services Grp Inc | C. Justin Jacobs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 31,382 | 31,382 | - | - | Restricted Stock Units | |
| Las Vegas Sands | D. Hudson Zachary | EVP and Global General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 31,374 | 31,374 | - | - | Restricted Stock Units | |
| Natera Inc | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 31,352 | 198,403 (0%) | 0% | - | Common Stock | |
| UMB Fin Corp | J. Kemper Mariner | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 30,568 | 267,303 (0%) | 0% | 0 | Common Stock | |
| AMEX | D. Williams Anre | Group Pres., Enterprise Serv. | 29 Jan 2024 | 30,359 | 30,359 | - | - | Employee Stock Option (Right to Buy) | ||
| Security National Fin Corp (Class A) | S. Andrew Quist | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 30,289 | 77,993 | - | - | Employee Stock Option (right to buy) | |
| Ameriprise Financial | James Cracchiolo M. | Director, CHAIRMAN AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 393.11 per share. | 29 Jan 2024 | 30,262 | 188,336 (0%) | 0% | 393.1 | 11,896,295 | Common Stock |
| SL Green Realty Corp | DiLiberto Matthew | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 30,208 | 171,723 | - | - | LTIP Units | |
| Alpha Metallurgical Resources Inc | Nicholson Roger L. | CAO, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.05 per share. | 29 Jan 2024 | 30,078 | 46,720 (0%) | 0% | 386.1 | 11,611,612 | Common Stock, $0.01 par value per share |
| Alpha & Omega Semiconductor Ltd | Mike F. Chang | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 30,000 | 0 | - | - | Employee Share Option (right to buy) | |
| Alpha & Omega Semiconductor Ltd | F. Mike Chang | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.44 per share. | 29 Jan 2024 | 30,000 | 4,530,286 (18%) | 0% | 7.4 | 223,200 | Common Shares |
| Alpha & Omega Semiconductor Ltd | Chang F. Mike | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.91 per share. | 29 Jan 2024 | 30,000 | 4,500,286 (18%) | 0% | 26.9 | 807,384 | Common Shares |
| Leap Therapeutics Inc | J. Thomas Dietz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Odyssey Marine Exploration Inc | Siegel Todd E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Odyssey Marine Exploration Inc | Jon D. Sawyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Odyssey Marine Exploration Inc | Mark Justh B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Opko Health Inc | M. Richard Krasno | Director | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 29 Jan 2024 | 30,000 | 103,333 (0%) | 0% | 1.0 | 29,838 | Common Stock |
| Vaxcyte Inc | Grant Pickering E. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.79 per share. | 29 Jan 2024 | 30,000 | 405,814 | - | 1.8 | 53,700 | Common Stock |
| Vaxcyte Inc | Pickering Grant E. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 30,000 | 75,225 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 66.03 per share. | 29 Jan 2024 | 30,000 | 375,814 | - | 66.0 | 1,980,900 | Common Stock |
| AAON Inc | Norman H. Asbjornson | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2024 | 29,736 | 13,376,908 (25%) | 0% | 0 | Common Stock, par value $.004 | |
| Viemed Healthcare Inc | Trae Fitzgerald | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 29,383 | 29,383 | - | - | Restricted Stock Units | |
| Crane Holdings Co. | Max Mitchell H. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.61 per share. | 29 Jan 2024 | 29,375 | 358,349 (0%) | 0% | 113.6 | 3,337,294 | Common Stock |
| Roblox Corp (Class A) | Daniel Sturman | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.40 per share. | 29 Jan 2024 | 29,368 | 511,545 | - | 3.4 | 99,998 | Class A Common Stock |
| Roblox Corp (Class A) | Sturman Daniel | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 29,368 | 753,563 | - | - | Stock Option (Right to Buy) | |
| Security National Fin Corp (Class A) | Andrew S. Quist | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 28,847 | 106,840 | - | - | Employee Stock Option (right to buy) | |
| Alcoa Corp | Oplinger F. William | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.91 per share. | 29 Jan 2024 | 28,653 | 205,982 (0%) | 0% | 30.9 | 885,664 | Common Stock, par value $0.01 per share |
| Exlservice Hldgs Inc | Vikas Bhalla | EVP & Head of Outsourcing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.29 per share. | 29 Jan 2024 | 28,626 | 132,883 (0%) | 0% | 32.3 | 924,334 | Common Stock, par value $0.001 per share |
| Levi Strauss & Co. - Ordinary Shares Cls A | David Jedrzejek | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 28,625 | 28,625 | - | - | Stock Appreciation Rights | |
| Exlservice Hldgs Inc | Vivek Jetley | EVP and Head of Analytics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.29 per share. | 29 Jan 2024 | 28,589 | 327,857 (0%) | 0% | 32.3 | 923,139 | Common Stock, par value $0.001 per share |
| Las Vegas Sands | Dumont Patrick | Director, President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 28,508 | 352,005 (0%) | 0% | 0 | Common Stock | |
| Las Vegas Sands | Patrick Dumont | Director, President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 28,508 | 57,877 | - | - | Restricted Stock Units | |
| SL Green Realty Corp | Levine Andrew S. | CHIEF LEGAL OFFICER & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 28,050 | 244,544 | - | - | LTIP Units | |
| AMEX | Seeger E. Laureen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 27,543 | 27,543 | - | - | Employee Stock Option (Right to Buy) | |
| Exlservice Hldgs Inc | Nicolelli Maurizio | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.29 per share. | 29 Jan 2024 | 27,515 | 132,520 (0%) | 0% | 32.3 | 888,459 | Common Stock, par value $0.001 per share |
| Security National Fin Corp (Class A) | Quist S. Andrew | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 27,473 | 134,313 | - | - | Employee Stock Option (right to buy) | |
| Relmada Therapeutics Inc | Traversa Sergio | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 29 Jan 2024 | 27,460 | 244,024 (1%) | 0% | 4.0 | 109,752 | Common Stock |
| Fiserv | Guy Chiarello | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 26,996 | 168,172 (0%) | 0% | 0 | Common Stock | |
| Viemed Healthcare Inc | W. Todd Zehnder | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 26,842 | 26,842 | - | - | Phantom Share Units | |
| Viemed Healthcare Inc | Michael Moore | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 26,842 | 26,842 | - | - | Phantom Share Units | |
| Exlservice Hldgs Inc | Narasimha Kini | EVP, Emerging Bus Unit Leader | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 26,600 | 193,584 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Horace Mann Educators Corp | Zuraitis Marita | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.88 per share. | 29 Jan 2024 | 26,216 | 305,815 (0%) | 0% | 28.9 | 757,118 | Common Stock |
| Horace Mann Educators Corp | Marita Zuraitis | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 37.14 per share. | 29 Jan 2024 | 26,216 | 279,599 (0%) | 0% | 37.1 | 973,636 | Common Stock |
| Horace Mann Educators Corp | Zuraitis Marita | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 26,216 | 3,618 | - | - | Employee Stock Option (right to buy) | |
| Cullinan Oncology Inc | Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 26,003 | 110,331 | - | - | Stock Option (Right to Buy) | |
| Caesars Entertainment | Reeg R. Thomas | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.43 per share. | 29 Jan 2024 | 25,866 | 434,600 (0%) | 0% | 45.4 | 1,175,092 | Common Stock |
| Viemed Healthcare Inc | Jerome Cambre | Vice President of Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,857 | 25,857 | - | - | Restricted Stock Units | |
| Baker Hughes | Lorenzo Simonelli | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.00 per share. | 29 Jan 2024 | 25,470 | 574,273 (0%) | 0% | 30 | 764,100 | Class A Common Stock |
| AMEX | Buckminster Douglas E. | Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.43 per share. | 29 Jan 2024 | 25,317 | 110,151 (0%) | 0% | 201.4 | 5,099,603 | Common Stock |
| AMEX | Marrs Anna | Group Pres., GCS and CFR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,039 | 25,039 | - | - | Employee Stock Option (Right to Buy) | |
| Abbott | Wainer F. Andrea | EXECUTIVE VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 112.50 per share. | 29 Jan 2024 | 25,000 | 65,027 (0%) | 0% | 112.5 | 2,812,500 | Common shares without par value |
| Abbott | Wainer Andrea F. | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.40 per share. | 29 Jan 2024 | 25,000 | 90,027 (0%) | 0% | 44.4 | 1,110,000 | Common shares without par value |
| Abbott | Wainer Andrea F. | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 13,271 | - | - | Option (right to buy) | |
| Leap Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Richard Schilsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Li William W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Joseph Loscalzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Nissim Mashiach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | James H. Cavanaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Christian Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Intuitive Machines Inc (Class A) | Steven Vontur | Interim CFO & Corp. Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 79,500 | - | 0 | Class A Common Stock | |
| Pegasystems Inc | Trefler Alan | Chief of Clients and Markets | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 24,553 | 0 | - | - | Stock Options | |
| Pegasystems Inc | Trefler Alan | Chief of Clients and Markets | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.05 per share. | 29 Jan 2024 | 24,553 | 50,742 (0%) | 0% | 20.1 | 492,288 | Common stock |
| Intuitive Surgical | Guthart Gary S. | Director, CEO | Sale of securities on an exchange or to another person at price $ 376.06 per share. | 29 Jan 2024 | 24,325 | 9,425 (0%) | 0% | 376.1 | 9,147,669 | Common Stock |
| Charles River Labs | Foster C. James | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 24,253 | 239,370 (0%) | 0% | 0 | Common Stock | |
| SL Green Realty Corp | Marc Holliday | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 23,832 | 1,263,048 | - | - | LTIP Units | |
| Charles River Labs | James C. Foster | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 23,741 | 238,858 (0%) | 0% | 0 | Common Stock | |
| AMEX | Monique Herena | Chief Colleague Experience Off | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 23,546 | 37,420 (0%) | 0% | 201.4 | 4,742,871 | Common Stock |
| WisdomTree Inc | Marci Frankenthaler | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 22,716 | 250,824 (0%) | 0% | 0 | Common Stock | |
| WisdomTree Inc | Frankenthaler Marci | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 22,716 | 0 | - | - | Performance Based Restricted Stock Units | |
| AMEX | C. Jeffery Campbell | Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.43 per share. | 29 Jan 2024 | 22,671 | 145,279 (0%) | 0% | 201.4 | 4,566,620 | Common Stock |
| Fastly Inc (Class A) | Bergman Artur | Director, Chief Architect | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 29 Jan 2024 | 21,875 | 6,079,994 (8%) | 0% | 21.0 | 460,031 | Class A Common Stock |
| Exelon | Calvin G. Butler | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 21,811 | 43,620 | - | - | 2023 Restricted Stock Units | |
| Exelon | Calvin Butler G. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 21,811 | 84,124 (0%) | 0% | - | Common Stock | |
| Horace Mann Educators Corp | Zuraitis Marita | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 37.02 per share. | 29 Jan 2024 | 21,600 | 279,599 (0%) | 0% | 37.0 | 799,589 | Common Stock |
| Ameriprise Financial | Berman S. Walter | EXECUTIVE VP AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 21,544 | 31,842 (0%) | 0% | 0 | Common Stock | |
| A10 Networks Inc | Dhrupad Trivedi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.58 per share. | 29 Jan 2024 | 21,498 | 461,507 (0%) | 0% | 13.6 | 291,943 | Common Stock |
| SL Green Realty Corp | Levine Andrew S. | CHIEF LEGAL OFFICER & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 21,459 | 281,230 | - | - | LTIP Units | |
| Exelon | Khouzami V. Carim | CEO of BGE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 21,236 | 0 | - | - | 2021-2023 Performance Shares | |
| Exelon | Michael Innocenzo A. | CEO, PECO Energy Co. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 21,236 | 89,299 (0%) | 0% | - | Common Stock | |
| Exelon | Khouzami Carim V. | CEO of BGE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 21,236 | 21,236 | - | - | 2021-2023 Performance Shares | |
| Exelon | V. Carim Khouzami | CEO of BGE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 21,236 | 33,284 (0%) | 0% | - | Common Stock | |
| Exelon | A. Michael Innocenzo | CEO, PECO Energy Co. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 21,236 | 21,236 | - | - | 2021-2023 Performance Shares | |
| Exelon | A. Innocenzo Michael | CEO, PECO Energy Co. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 21,236 | 0 | - | - | 2021-2023 Performance Shares | |
| AMEX | Denise Pickett | Pres., GSG and TLS | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 21,151 | 33,854 (0%) | 0% | 201.4 | 4,260,446 | Common Stock |
| Alpha Metallurgical Resources Inc | Horn E. Daniel | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.05 per share. | 29 Jan 2024 | 20,733 | 35,134 (0%) | 0% | 386.1 | 8,003,975 | Common Stock, $0.01 par value per share |
| AMEX | Pickett Denise | Pres., GSG and TLS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 20,518 | 43,049 (0%) | 0% | 0 | Common Stock | |
| AMEX | Pickett Denise | Pres., GSG and TLS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 20,518 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| AMEX | Denise Pickett | Pres., GSG and TLS | Sale of securities on an exchange or to another person at price $ 203.96 per share. | 29 Jan 2024 | 20,518 | 39,119 (0%) | 0% | 204.0 | 4,184,851 | Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | O’Neill Elizabeth | EVP & Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 20,414 | 84,860 (0%) | 0% | 0 | Class A Common Stock | |
| Baker Hughes | Claudia Borras Maria | EVP, Oilfield Services & Equip | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 20,227 | 0 | - | - | Restricted Stock Unit 01_21 | |
| Baker Hughes | Borras Maria Claudia | EVP, Oilfield Services & Equip | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 20,227 | 105,403 (0%) | 0% | - | Class A Common Stock | |
| Exelon | Gayle Littleton | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.29 per share. | 29 Jan 2024 | 20,047 | 53,179 (0%) | 0% | 35.3 | 707,459 | Common Stock |
| Beacon Fin Corp | A. Zaitzeff Michael | Director | Sale of securities on an exchange or to another person at price $ 24.73 per share. | 29 Jan 2024 | 20,028 | 288,483 (0%) | 0% | 24.7 | 495,369 | Common Stock |
| Dyne Therapeutics Inc | T. Brumm Joshua | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2024 | 20,000 | 564,971 | - | 0 | Common Stock | |
| GSI Tech Inc | Douglas Schirle M. | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| GSI Tech Inc | Lasserre Didier | VP, Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| GSI Tech Inc | Patrick T. Chuang | Senior VP, Memory Design | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| GSI Tech Inc | Wu Bor-Tay | VP, Taiwan Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 400.41 per share. | 29 Jan 2024 | 19,825 | 15,178 (0%) | 0% | 400.4 | 7,938,156 | Class A Common Stock |
| AMEX | Joabar Raymond Donald | Grp. Pres., GMNS | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 19,355 | 32,021 (0%) | 0% | 201.4 | 3,898,678 | Common Stock |
| Exlservice Hldgs Inc | Anita Mahon | EVP & Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.29 per share. | 29 Jan 2024 | 19,086 | 84,573 (0%) | 0% | 32.3 | 616,287 | Common Stock, par value $0.001 per share |
| SL Green Realty Corp | Mathias Andrew W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 19,066 | 999,523 | - | - | LTIP Units | |
| AMEX | Anre Williams D. | Group Pres., Enterprise Serv. | 29 Jan 2024 | 18,994 | 151,505 (0%) | 0% | 201.4 | 3,825,961 | Common Stock | |
| Las Vegas Sands | Robert Goldstein G. | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.51 per share. | 29 Jan 2024 | 18,845 | 36,744 (0%) | 0% | 49.5 | 933,016 | Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Tracy Layney | EVP and Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 18,844 | 57,362 (0%) | 0% | 0 | Class A Common Stock | |
| AMEX | Laureen E. Seeger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.43 per share. | 29 Jan 2024 | 18,701 | 80,321 (0%) | 0% | 201.4 | 3,766,942 | Common Stock |
| AMEX | Monique Herena | Chief Colleague Experience Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 18,466 | 18,466 | - | - | Employee Stock Option (Right to Buy) | |
| Fiserv | Robert W. Hau | Chief Financial Officer | 29 Jan 2024 | 18,155 | 148,508 (0%) | 0% | 0 | Common Stock | ||
| Exelon | Jones M. Jeanne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 18,011 | 18,011 | - | - | 2024 Restricted Stock Units | |
| Caesars Entertainment | Thomas Reeg R. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 17,972 | 17,972 | - | - | Restricted Stock Units | |
| Caesars Entertainment | R. Thomas Reeg | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 17,972 | 427,920 (0%) | 0% | 0 | Common Stock | |
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 29 Jan 2024 | 17,925 | 3,976,891 | - | - | Class B Common Stock | ||
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 29 Jan 2024 | 17,925 | 17,925 (0%) | 0% | 0 | Class A Common Stock | ||
| Exelon | Glockner David | EVP Compliance, Audit & Risk | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.29 per share. | 29 Jan 2024 | 17,838 | 53,159 (0%) | 0% | 35.3 | 629,503 | Common Stock |
| Exelon | G. Butler Calvin | Director, President & CEO | Sale or transfer of securities back to the company at price $ 35.29 per share. | 29 Jan 2024 | 17,821 | 106,318 (0%) | 0% | 35.3 | 628,903 | Common Stock |
| Alcoa Corp | Jones Tammi A | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.91 per share. | 29 Jan 2024 | 17,642 | 66,886 (0%) | 0% | 30.9 | 545,314 | Common Stock, par value $0.01 per share |
| Abbott | Wainer Andrea F. | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 17,500 | 46,949 | - | - | Option (right to buy) | |
| Abbott | Wainer F. Andrea | EXECUTIVE VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 112.50 per share. | 29 Jan 2024 | 17,500 | 65,027 (0%) | 0% | 112.5 | 1,968,750 | Common shares without par value |
| Abbott | F. Wainer Andrea | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.94 per share. | 29 Jan 2024 | 17,500 | 82,527 (0%) | 0% | 59.9 | 1,048,950 | Common shares without par value |
| Charles River Labs | Foster James C. | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.67 per share. | 29 Jan 2024 | 17,436 | 227,827 (0%) | 0% | 144.7 | 2,522,466 | Common Stock |
| Charles River Labs | C. James Foster | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 17,436 | 0 | - | - | Stock Options (Right to Buy) | |
| Ameriprise Financial | William F. Truscott | CEO, GLOBAL ASSET MANAGEMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 16,971 | 27,995 (0%) | 0% | 0 | Common Stock | |
| AMEX | Anna Marrs | Group Pres., GCS and CFR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.43 per share. | 29 Jan 2024 | 16,936 | 31,141 (0%) | 0% | 201.4 | 3,411,418 | Common Stock |
| AMEX | Pickett Denise | Pres., GSG and TLS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 16,588 | 16,588 | - | - | Employee Stock Option (Right to Buy) | |
| AMEX | Pickett Denise | Pres., GSG and TLS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 16,588 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| AMEX | Denise Pickett | Pres., GSG and TLS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 16,588 | 59,637 (0%) | 0% | 0 | Common Stock | |
| AMEX | Pickett Denise | Pres., GSG and TLS | Sale of securities on an exchange or to another person at price $ 203.96 per share. | 29 Jan 2024 | 16,588 | 22,531 (0%) | 0% | 204.0 | 3,383,288 | Common Stock |
| Exelon | Littleton Gayle | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 16,505 | 16,505 | - | - | 2024 Restricted Stock Units | |
| ON24 Inc | Sharan Sharat | Director, President and Chief Executive, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 29 Jan 2024 | 16,440 | 2,560,895 | - | 7.8 | 128,234 | Common Stock |
| Security National Fin Corp (Class A) | Andrew S. Quist | Director, Vice President/General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 15,901 | 15,901 | - | - | Employee Stock Option (right to buy) | |
| WisdomTree Inc | Peck William Bradley | Head of Digital Assets | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 15,830 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | William Peck Bradley | Head of Digital Assets | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 15,830 | 202,388 (0%) | 0% | 0 | Common Stock | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 342.44 per share. | 29 Jan 2024 | 15,781 | 220,424 (0%) | 0% | 342.4 | 5,403,998 | Common Stock |
| WisdomTree Inc | Alexis Marinof | Head of Europe | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Jan 2024 | 15,544 | 272,925 (0%) | 0% | 0 | Common Stock | |
| Paychex | Mark A. Bottini | Sr. VP of Sales | 29 Jan 2024 | 15,481 | 98,171 (0%) | 0% | 41.7 | 645,558 | Common Stock | |
| Paychex | Bottini Mark A. | Sr. VP of Sales | 29 Jan 2024 | 15,481 | 0 | - | - | Stock Option | ||
| Paychex | Mark A. Bottini | Sr. VP of Sales | 29 Jan 2024 | 15,481 | 82,690 (0%) | 0% | 120.5 | 1,865,925 | Common Stock | |
| Caesars Entertainment | Reeg R. Thomas | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 15,213 | 0 | - | - | Restricted Stock Unit | |
| Caesars Entertainment | R. Reeg Thomas | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 15,213 | 409,948 (0%) | 0% | 0 | Common Stock | |
| AMEX | Raymond Joabar Donald | Grp. Pres., GMNS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 15,179 | 15,179 | - | - | Employee Stock Option (Right to Buy) | |
| Annaly Cap Management Inc | David L. Finkelstein | Director, CEO and CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.19 per share. | 29 Jan 2024 | 15,071 | 538,969 (0%) | 0% | 19.2 | 289,212 | Common Stock |
| GSI Tech Inc | Ping Wu | VP, U.S. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| OSI Systems Inc | Sze Victor S. | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 131.22 per share. | 29 Jan 2024 | 15,000 | 78,116 (0%) | 0% | 131.2 | 1,968,300 | Common Stock |
| Relmada Therapeutics Inc | Shenouda Maged | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.89 per share. | 29 Jan 2024 | 15,000 | 28,028 (0%) | 0% | 3.9 | 58,323 | Common Stock |
| Hologic | Oberton Karleen M. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 29 Jan 2024 | 14,940 | 103,916 (0%) | 0% | 75 | 1,120,500 | Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Stirling Lisa | Global Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 14,918 | 38,524 (0%) | 0% | 0 | Class A Common Stock | |
| Caesars Entertainment | Carano L. Anthony | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 14,645 | 209,932 (0%) | 0% | 0 | Common Stock | |
| Caesars Entertainment | L. Anthony Carano | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 14,645 | 29,292 | - | - | Restricted Stock Unit | |
| Exelon | Michael A. Innocenzo | CEO, PECO Energy Co. | Sale or transfer of securities back to the company at price $ 35.29 per share. | 29 Jan 2024 | 14,534 | 65,532 (0%) | 0% | 35.3 | 512,905 | Common Stock |
| Relmada Therapeutics Inc | Ence Charles S. | CA and CO | Purchase of securities on an exchange or from another person at price $ 3.87 per share. | 29 Jan 2024 | 14,500 | 25,300 (0%) | 0% | 3.9 | 56,053 | Common Stock |
| CarMax | A. Jill Livesay | VP, Controller & PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.38 per share. | 29 Jan 2024 | 14,199 | 23,267 (0%) | 0% | 58.4 | 828,938 | Common Stock |
| CarMax | A. Livesay Jill | VP, Controller & PAO | Sale of securities on an exchange or to another person at price $ 70.89 per share. | 29 Jan 2024 | 14,199 | 9,068 (0%) | 0% | 70.9 | 1,006,567 | Common Stock |
| CarMax | A. Jill Livesay | VP, Controller & PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 14,199 | 0 | - | - | Stock Options (Right to Buy) | |
| Cullinan Oncology Inc | Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 13,997 | 0 | - | - | Stock Option (Right to Buy) | |
| First Commonwealth Fin Corp | T. Price Michael | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 13,800 | 48,550 | - | - | Restricted Stock Units-Service Based | |
| Fiserv | Guy Chiarello | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.91 per share. | 29 Jan 2024 | 13,774 | 154,398 (0%) | 0% | 142.9 | 1,968,442 | Common Stock |
| Sutro Biopharma Inc | J. Newell William | Director, CEO | 29 Jan 2024 | 13,750 | 0 | - | - | Restricted Stock Unit (RSU) | ||
| Sutro Biopharma Inc | Newell J. William | Director, CEO | 29 Jan 2024 | 13,750 | 178,566 (0%) | 0% | 0 | Common Stock | ||
| Alcoa Corp | William F. Oplinger | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.91 per share. | 29 Jan 2024 | 13,714 | 168,736 (0%) | 0% | 30.9 | 423,900 | Common Stock, par value $0.01 per share |
| Pegasystems Inc | Trefler Alan | Chief of Clients and Markets | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.31 per share. | 29 Jan 2024 | 13,705 | 37,037 (0%) | 0% | 49.3 | 675,794 | Common stock |
| Relmada Therapeutics Inc | Charles S. Ence | CA and CO | Purchase of securities on an exchange or from another person at price $ 4.05 per share. | 29 Jan 2024 | 13,670 | 38,970 (0%) | 0% | 4.1 | 55,429 | Common Stock |
| Fiserv | Bisignano Frank J. | Director, Chairman, President and CEO | 29 Jan 2024 | 13,639 | 2,892,664 (0%) | 0% | 142.9 | 1,949,149 | Common Stock | |
| ON24 Inc | Sharan Sharat | Director, President and Chief Executive, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.56 per share. | 29 Jan 2024 | 13,537 | 2,547,358 | - | 7.6 | 102,302 | Common Stock |
| Exlservice Hldgs Inc | Kini Narasimha | EVP, Emerging Bus Unit Leader | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.29 per share. | 29 Jan 2024 | 13,401 | 180,183 (0%) | 0% | 32.3 | 432,718 | Common Stock, par value $0.001 per share |
| Exelon | David Glockner | EVP Compliance, Audit & Risk | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 13,279 | 13,279 | - | - | 2024 Restricted Stock Units | |
| Triumph Fin Inc | Joseph Schreyer Edward | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 72.43 per share. | 29 Jan 2024 | 12,820 | 50,939 (0%) | 0% | 72.4 | 928,553 | Common Stock |
| Charles River Labs | James Foster C. | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.56 per share. | 29 Jan 2024 | 12,710 | 215,117 (0%) | 0% | 224.6 | 2,854,158 | Common Stock |
| Caesars Entertainment | Yunker Bret | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 12,476 | 129,443 (0%) | 0% | 0 | Common Stock | |
| Caesars Entertainment | Bret Yunker | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 12,476 | 24,952 | - | - | Restricted Stock Unit | |
| ServisFirst Bancshares Inc | Broughton A. Thomas | Director, Chairman, President, & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 12,399 | 272,090 (0%) | 0% | 0 | Common Stock | |
| AMEX | Herena Monique | Chief Colleague Experience Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.43 per share. | 29 Jan 2024 | 12,304 | 25,116 (0%) | 0% | 201.4 | 2,478,395 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | CHIEF PORT. STRAT & ALNCE OFCR | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 29 Jan 2024 | 12,185 | 12,803 (0%) | 0% | 5 | 60,925 | Common Stock |
| Ameriprise Financial | Walter Berman S. | EXECUTIVE VP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 393.11 per share. | 29 Jan 2024 | 12,087 | 19,755 (0%) | 0% | 393.1 | 4,751,521 | Common Stock |
| Enliven Therapeutics Inc | P. Joseph Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 15.85 per share. | 29 Jan 2024 | 12,000 | 0 | - | 15.9 | 190,256 | Common Stock |
| Enliven Therapeutics Inc | P. Joseph Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 12,000 | 284,550 | - | - | Stock Option (right to buy) | |
| Enliven Therapeutics Inc | P. Joseph Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 29 Jan 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| AMEX | Rutledge Elizabeth | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 11,972 | 85,272 (0%) | 0% | 201.4 | 2,411,520 | Common Stock |
| Citizens Inc (Class A) | P. Conklin Jeffery | VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 11,816 | 127,598 (0%) | 0% | - | Citizens, Inc. Class A Common Stock | |
| Citizens Inc (Class A) | Jeffery P. Conklin | VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 11,816 | 0 | - | - | Restricted Stock Units | |
| TimkenSteel Corp | Westbrooks Kris | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 29 Jan 2024 | 11,812 | 171,463 (0%) | 0% | 20.6 | 243,612 | Common Shares |
| TimkenSteel Corp | Westbrooks Kris | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.26 per share. | 29 Jan 2024 | 11,812 | 183,275 (0%) | 0% | 5.3 | 62,131 | Common Shares |
| TimkenSteel Corp | Westbrooks Kris | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 11,812 | 29,044 | - | - | Nonqualified Stock Option (Right to buy) | |
| Levi Strauss & Co. - Ordinary Shares Cls A | Jedrzejek David | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 11,777 | 47,915 (0%) | 0% | 0 | Class A Common Stock | |
| UMB Fin Corp | Kemper Mariner J. | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.47 per share. | 29 Jan 2024 | 11,689 | 255,614 (0%) | 0% | 83.5 | 975,681 | Common Stock |
| Alcoa Corp | S. Beerman Molly | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 11,655 | 92,626 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Alcoa Corp | Renato Bacchi | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 11,655 | 89,052 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| WisdomTree Inc | Ziemba M. Peter | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Jan 2024 | 11,488 | 1,048,386 (0%) | 0% | 0 | Common Stock | |
| Alcoa Corp | Jones Tammi A | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.91 per share. | 29 Jan 2024 | 11,364 | 51,242 (0%) | 0% | 30.9 | 351,261 | Common Stock, par value $0.01 per share |
| Citizens Inc (Class A) | Mauldin Robert M. | VP, Chief Marketing Officer | 29 Jan 2024 | 11,331 | 0 | - | - | Restricted Stock Units | ||
| Citizens Inc (Class A) | Mauldin M. Robert | VP, Chief Marketing Officer | 29 Jan 2024 | 11,331 | 86,670 (0%) | 0% | - | Citizens, Inc. Class A Common Stock | ||
| Exelon | Glockner David | EVP Compliance, Audit & Risk | Sale or transfer of securities back to the company at price $ 35.29 per share. | 29 Jan 2024 | 11,324 | 41,835 (0%) | 0% | 35.3 | 399,624 | Common Stock |
| AMEX | Pickett Denise | Pres., GSG and TLS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.43 per share. | 29 Jan 2024 | 11,323 | 22,531 (0%) | 0% | 201.4 | 2,280,792 | Common Stock |
| Palo Alto | Klarich Lee | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 343.38 per share. | 29 Jan 2024 | 11,191 | 209,233 (0%) | 0% | 343.4 | 3,842,743 | Common Stock |
| AMEX | Skyler Jennifer | Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 201.43 per share. | 29 Jan 2024 | 11,174 | 24,843 (0%) | 0% | 201.4 | 2,250,779 | Common Stock |
| Caesars Entertainment | Carano L. Anthony | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.43 per share. | 29 Jan 2024 | 11,170 | 198,762 (0%) | 0% | 45.4 | 507,453 | Common Stock |
| Exelon | Quiniones Gil C. | CEO of ComEd | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 11,119 | 11,119 | - | - | 2024 Restricted Stock Units | |
| Relmada Therapeutics Inc | Charles Ence S. | CA and CO | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 29 Jan 2024 | 10,800 | 10,800 (0%) | 0% | 3.7 | 39,438 | Common Stock |
| Relmada Therapeutics Inc | Shenouda Maged | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 29 Jan 2024 | 10,800 | 13,028 (0%) | 0% | 3.7 | 39,450 | Common Stock |
| Viemed Healthcare Inc | Jeremy Trahan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 10,774 | 10,774 | - | - | Phantom Share Units | |
| Charles River Labs | Foster C. James | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 10,757 | 228,613 (0%) | 0% | 220.3 | 2,369,552 | Common Stock |
| AMEX | Joabar Donald Raymond | Grp. Pres., GMNS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.43 per share. | 29 Jan 2024 | 10,730 | 21,291 (0%) | 0% | 201.4 | 2,161,344 | Common Stock |
| Charles River Labs | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 10,540 | 228,318 (0%) | 0% | 220.3 | 2,321,751 | Common Stock |
| Ameriprise Financial | Joseph E. Sweeney | PRES-AWM PRODUCTS & SERVICES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 10,505 | 19,926 (0%) | 0% | 0 | Common Stock | |
| UMB Fin Corp | James Rine D. | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 10,220 | 54,563 (0%) | 0% | 0 | Common Stock | |
| Viemed Healthcare Inc | William Frazier | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 10,201 | 10,201 | - | - | Restricted Stock Units | |
| Agilysys Inc | Wood William David | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.45 per share. | 29 Jan 2024 | 10,000 | 50,391 (0%) | 0% | 85.5 | 854,500 | Common Stock |
| Westamerica Bancorp | L. Payne David | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 49.51 per share. | 29 Jan 2024 | 10,000 | 268,689 (0%) | 0% | 49.5 | 495,133 | Common Stock |
| Westamerica Bancorp | David L. Payne | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 48.28 per share. | 29 Jan 2024 | 10,000 | 278,689 (1%) | 0% | 48.3 | 482,813 | Common Stock |
| Salesforce | Tallapragada Srinivas | Pres/Chief Engineering Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 154.14 per share. | 29 Jan 2024 | 10,000 | 70,416 (0%) | 0% | 154.1 | 1,541,400 | Common Stock |
| Salesforce | Tallapragada Srinivas | Pres/Chief Engineering Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 10,000 | 41,145 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Exelon | Khouzami Carim V. | CEO of BGE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.29 per share. | 29 Jan 2024 | 9,831 | 23,453 (0%) | 0% | 35.3 | 346,936 | Common Stock |
| AMEX | Pickett Denise | Pres., GSG and TLS | Sale of securities on an exchange or to another person at price $ 203.96 per share. | 29 Jan 2024 | 9,828 | 12,703 (0%) | 0% | 204.0 | 2,004,519 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.